Skip to main content
ESSA Pharma Inc. (EPIX)
Oct 9, 2025 - EPIX was delisted (reason: acquired by XenoTherapeutics)
0.195
-0.006 (-3.03%)
Inactive · Last trade price on Oct 8, 2025

ESSA Pharma Cash Flow Statement

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Jun '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2019 - 2015
Net Income
-25.27-28.54-26.58-35.1-36.81-23.45
Upgrade
Depreciation & Amortization
0.090.090.120.120.110.11
Upgrade
Loss (Gain) From Sale of Investments
-0.75-0.92-0.670.07--
Upgrade
Stock-Based Compensation
5.246.545.017.899.487.52
Upgrade
Other Operating Activities
10.530.01-0.2-0.140.07
Upgrade
Change in Accounts Receivable
-0.09-0.03-0.130.48-0.160.09
Upgrade
Change in Accounts Payable
-1.86-0.241.24-1.632.67-0.05
Upgrade
Change in Income Taxes
------0.02
Upgrade
Change in Other Net Operating Assets
0.76-0.151.230.37-0.56-1.26
Upgrade
Operating Cash Flow
-20.88-22.72-19.78-28-25.42-16.98
Upgrade
Investment in Securities
20.7991.79-3.53-53.05-35.03-22.01
Upgrade
Other Investing Activities
----0.010.27
Upgrade
Investing Cash Flow
20.7991.79-3.53-53.05-35.01-21.74
Upgrade
Long-Term Debt Repaid
---0.14-0.13-0.1-4.01
Upgrade
Net Debt Issued (Repaid)
---0.14-0.13-0.1-4.01
Upgrade
Issuance of Common Stock
0.060.930.070.39151.3249.33
Upgrade
Other Financing Activities
-----9.23-3.54
Upgrade
Financing Cash Flow
0.060.93-0.070.25141.9941.78
Upgrade
Foreign Exchange Rate Adjustments
0.010.0100.05-0.06-0.06
Upgrade
Net Cash Flow
-0.0370.01-23.37-80.7581.53
Upgrade
Free Cash Flow
-20.88-22.72-19.78-28-25.42-16.98
Upgrade
Free Cash Flow Per Share
-0.47-0.51-0.45-0.64-0.66-0.76
Upgrade
Cash Interest Paid
-----0.03
Upgrade
Levered Free Cash Flow
-14.56-15.2-12.62-15.88-11.68-8.92
Upgrade
Unlevered Free Cash Flow
-14.56-15.2-12.62-15.87-11.67-8.78
Upgrade
Change in Working Capital
-1.2-0.422.34-0.781.95-1.24
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.